SEC Form 4 · accession 0001144204-15-018080
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 20, 2015 | X | 634,516 | $2.77 | A | 13,145,097 | I | By LVP |
| Common StockF1 | Mar 20, 2015 | S | 300,447 | $5.85 | D | 12,844,650 | I | By LVP |
| Common StockF1 | Mar 20, 2015 | X | 486,443 | $2.77 | A | 13,331,093 | I | By LVP |
| Common StockF1 | Mar 20, 2015 | S | 230,333 | $5.85 | D | 13,100,760 | I | By LVP |
| Common StockF4 | Mar 20, 2015 | X | 9,750 | $2.77 | A | 182,742 | I | By LCA |
| Common StockF4 | Mar 20, 2015 | S | 4,617 | $5.85 | D | 178,125 | I | By LCA |
| Common StockF1 | Mar 24, 2015 | X | 1,130,709 | $2.77 | A | 14,231,469 | I | By LVP |
| Common StockF1 | Mar 24, 2015 | S | 554,348 | $5.65 | D | 13,677,121 | I | By LVP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy)F1 | $2.77 | Mar 20, 2015 | X | 634,516 | D | Mar 25, 2008 | Mar 24, 2015 | Common Stock | 634,516 | 1,130,709 | I |
| Warrant (Right to Buy)F1 | $2.77 | Mar 20, 2015 | X | 486,443 | D | Feb 6, 2009 | Mar 24, 2015 | Common Stock | 486,443 | 0 | I |
| Warrant (Right to Buy)F4 | $2.77 | Mar 20, 2015 | X | 9,750 | D | Feb 6, 2009 | Mar 24, 2015 | Common Stock | 9,750 | 0 | I |
| Warrant (Right to Buy)F1 | $2.77 | Mar 24, 2015 | X | 1,130,709 | D | Mar 25, 2008 | Mar 24, 2015 | Common Stock | 1,130,709 | 0 | I |
Explanation of responses
- F1Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). Patrick G. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP. Mr. Enright serves on the Board of Directors of the Issuer as the nominee of LVP. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP, except to the extent of his pecuniary interest therein.
- F2On March 20, 2015, LVP exercised a warrant to purchase 634,516 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 300,447 of such shares to pay the exercise price and issuing to LVP the remaining 334,069 shares. In connection with such exercise, the Issuer also paid to LVP $5.63 in cash in lieu of a fractional share.
- F3On March 20, 2015, LVP exercised a warrant to purchase 486,443 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 230,333 of such shares to pay the exercise price and issuing to LVP the remaining 256,110 shares. In connection with such exercise, the Issuer also paid to LVP $0.94 in cash in lieu of a fractional share.
- F4Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). Patrick G. Enright is a managing member of Longitude Capital, the sole general partner of LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LCA, except to the extent of his pecuniary interest therein.
- F5On March 20, 2015, LCA exercised a warrant to purchase 9,750 shares of the Issuer's common stock for an exercise price of $2.77 per share. LCA paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 4,617 of such shares to pay the exercise price and issuing to LCA the remaining 5,133 shares. In connection with such exercise, the Issuer also paid to LCA $1.95 in cash in lieu of a fractional share.
- F6On March 24, 2015, LVP exercised a warrant to purchase 1,130,709 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 554,348 of such shares to pay the exercise price and issuing to LVP the remaining 576,361 shares. In connection with such exercise, the Issuer also paid to LVP $2.27 in cash in lieu of a fractional share.